- Home
- SOGP vs NURO Comparison
SOGP vs NURO Comparison
Compare SOGP & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOGP
- NURO
- Stock Information
- Founded
- SOGP 2010
- NURO 1996
- Country
- SOGP Singapore
- NURO United States
- Employees
- SOGP N/A
- NURO N/A
- Industry
- SOGP
- NURO Medical/Dental Instruments
- Sector
- SOGP
- NURO Health Care
- Exchange
- SOGP NYSE
- NURO Nasdaq
- Market Cap
- SOGP 9.8M
- NURO 9.0M
- IPO Year
- SOGP 2020
- NURO N/A
- Fundamental
- Price
- SOGP $2.23
- NURO $4.37
- Analyst Decision
- SOGP
- NURO
- Analyst Count
- SOGP 0
- NURO 0
- Target Price
- SOGP N/A
- NURO N/A
- AVG Volume (30 Days)
- SOGP 134.6K
- NURO 7.6K
- Earning Date
- SOGP 01-01-0001
- NURO 03-25-2025
- Dividend Yield
- SOGP N/A
- NURO N/A
- EPS Growth
- SOGP N/A
- NURO N/A
- EPS
- SOGP N/A
- NURO N/A
- Revenue
- SOGP $250,401,822.00
- NURO $3,767,764.00
- Revenue This Year
- SOGP $37.39
- NURO N/A
- Revenue Next Year
- SOGP $3.88
- NURO N/A
- P/E Ratio
- SOGP N/A
- NURO N/A
- Revenue Growth
- SOGP N/A
- NURO N/A
- 52 Week Low
- SOGP $1.49
- NURO $2.66
- 52 Week High
- SOGP $4.00
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- SOGP 52.69
- NURO 57.17
- Support Level
- SOGP $2.07
- NURO $4.33
- Resistance Level
- SOGP $2.29
- NURO $4.42
- Average True Range (ATR)
- SOGP 0.14
- NURO 0.03
- MACD
- SOGP -0.01
- NURO -0.01
- Stochastic Oscillator
- SOGP 51.76
- NURO 23.53
About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)
Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.